CRYM Gene: Crystallin Mu – Structure, Function, and Clinical Significance

Comprehensive biomedical resource on CRYM (crystallin mu), including genomic data, expression, mutations, and associated diseases.

Gene Information Card

Symbol CRYM
Full Name crystallin mu
Gene Type protein-coding
Chromosomal Location 16p13.11-p12.3
NCBI Gene ID 1428 ncbi.nlm.nih.gov/gene/1428
Ensembl ID ENSG00000103319
UniProt ID Q14894
OMIM ID 123740
HGNC ID 2418
Aliases DFNA40, THBP, mu-crystallin

Description

CRYM encodes mu-crystallin, a cytosolic protein that binds thyroid hormone (T3) and functions as a ketimine reductase. It is expressed in various tissues including the inner ear and lens, and mutations are associated with autosomal dominant non-syndromic hearing loss (DFNA40) and possibly cataract. The protein is also implicated in cancer through altered expression.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Autosomal dominant non-syndromic hearing loss 40 (DFNA40) Missense mutations in CRYM disrupt thyroid hormone binding and ketimine reductase activity, leading to cochlear dysfunction. ClinVar, OMIM #616968
Cataract Reduced CRYM expression in lens epithelial cells may contribute to cataract formation via oxidative stress. PubMed, limited evidence
Thyroid hormone resistance (possible) CRYM binds T3; altered binding may affect local thyroid hormone signaling. UniProt, inferred

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Eye (retina) 8.2 Low
Inner ear (cochlea) 15.3 Medium
Kidney 6.1 Low
Liver 3.4 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 10.2 Moderate expression
HeLa 5.8 Low expression
SH-SY5Y 14.1 Higher expression
ARPE-19 7.5 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.94C>T (p.Arg32Trp) Missense Rare Loss of ketimine reductase activity; associated with DFNA40
c.184G>A (p.Gly62Ser) Missense Rare Reduced T3 binding; hearing loss
c.347T>C (p.Leu116Pro) Missense Rare Dominant negative effect; hearing loss
Mutation functional classification

Loss of Function (LOF)

Missense mutations (e.g., p.Arg32Trp) reduce or abolish ketimine reductase activity and T3 binding, leading to hearing loss.

Gain of Function (GOF)

Not reported for CRYM.

Dominant Negative (DN)

p.Leu116Pro is suggested to exert a dominant negative effect by interfering with dimerization or substrate binding.

Pathways

Thyroid hormone signaling pathway (Reactome: R-HSA-2408552)
Metabolism of amino acids and derivatives (Reactome: R-HSA-71291)

Protein Summary

Mu-crystallin (CRYM) is a 314-amino acid cytosolic protein that belongs to the ornithine cyclodeaminase/mu-crystallin family. It binds thyroid hormone (T3) with high affinity and functions as a NADP-dependent ketimine reductase, catalyzing the reduction of cyclic imines. The protein is highly expressed in the cochlea, brain, and retina. Mutations in CRYM cause autosomal dominant hearing loss (DFNA40) by impairing enzyme activity and T3 binding. Altered expression is also observed in certain cancers and cataract.

Related Products

Product name Cat.No. Species Gene ID
CRYM Knockout HEK293 Cell Line EDJ-KQ4359 Human 1428 Details Get a Quote
CRYM Knockout A-549 Cell Line EDJ-KQ26862 Human 1428 Details Get a Quote
CRYM Knockout HCT 116 Cell Line EDJ-KQ26863 Human 1428 Details Get a Quote
CRYM Knockout HeLa Cell Line EDJ-KQ52998 Human 1428 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: